Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC raised its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 2.0% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 76,704 shares of the biotechnology company's stock after purchasing an additional 1,503 shares during the period. Commonwealth Equity Services LLC owned 0.10% of Axon Enterprise worth $45,587,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Asset Dedication LLC increased its stake in shares of Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock worth $106,000 after acquiring an additional 18 shares during the last quarter. Bleakley Financial Group LLC increased its stake in shares of Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after acquiring an additional 20 shares during the last quarter. Venturi Wealth Management LLC increased its stake in shares of Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock worth $477,000 after acquiring an additional 21 shares during the last quarter. Insigneo Advisory Services LLC increased its stake in shares of Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after acquiring an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC increased its stake in shares of Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after acquiring an additional 24 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of brokerages have issued reports on AXON. The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research note on Monday, January 27th. Barclays reissued a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Finally, Needham & Company LLC reissued a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus target price of $604.67.

Insider Buying and Selling

In related news, Director Jeri Williams sold 307 shares of the business's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,792 shares of company stock worth $1,087,843 over the last 90 days. 5.70% of the stock is owned by insiders.

Axon Enterprise Stock Up 5.2 %

Shares of AXON traded up $28.12 during midday trading on Wednesday, hitting $568.11. The company had a trading volume of 575,915 shares, compared to its average volume of 852,230. The company's 50-day simple moving average is $592.66 and its 200-day simple moving average is $539.27. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market capitalization of $43.53 billion, a P/E ratio of 146.80, a P/E/G ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.